These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 336555)

  • 1. Are all nonsolid Mycobacterium leprae dead? Does a negative finding in the mouse foot pad indicate that there is actually no growth of M. leprae in the animals?
    Chang YT
    Int J Lepr Other Mycobact Dis; 1977; 45(3):235-40. PubMed ID: 336555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse foot pad growth of M. leprae in relation to bacteriological index.
    Bhatia VN; Balakrishnan S; Venkataramaniah HN; Harikrishnan S
    Lepr India; 1983 Apr; 55(2):247-51. PubMed ID: 6355651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse foot-pad studies with M. leprae--effect of desoxy fructo serotonin (DFS) and related compounds.
    Balakrishnan S; Mester L; Venkataramaniah HN; Bhatia VN
    Indian J Lepr; 1985; 57(2):323-8. PubMed ID: 3908578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current data on the bacteriology of leprosy].
    Grosset J; Guelpa-Lauras CC; Lecoeur H
    Acta Leprol; 1982; (86-87):35-45. PubMed ID: 6815996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on sulphone resistant strains of M. leprae in field and institutionalized cases of leprosy.
    Balakrishnan S; Seshadri PS; Neelan PN; Venkataramaniah HN; Harikrishnan S; Bhatia VN
    Lepr India; 1983 Jan; 55(1):71-5. PubMed ID: 6348413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mouse foot-pad technique for cultivation of Mycobacterium leprae.
    Levy L; Ji B
    Lepr Rev; 2006 Mar; 77(1):5-24. PubMed ID: 16715686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation viability/morphology in Mycobacterium leprae.
    Silva MT; Macedo PM; Portaels F; Pattyn SR
    Acta Leprol; 1984; 2(2-4):281-91. PubMed ID: 6398588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of strains of Mycobacterium leprae isolated prior to 1977 from patients with previously untreated lepromatous leprosy.
    Shepard CC; Rees RJ; Levy L; Pattyn SR; Baohong J; Dela Cruz EC
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):11-5. PubMed ID: 3519796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Drug-resistant proportion test" for M. leprae to quantify the proportion of drug-resistant M. leprae in a sample using the mouse foot pad.
    Almeida JG; Joseph PS; Sarangapani G; Chacko CJ
    Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):468-70. PubMed ID: 6399066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Considerations of the application of the foot pad technic in leprosy research.
    Shepard CC
    Int J Lepr; 1965; 33(3):Suppl:657-61. PubMed ID: 5322708
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative assessment of viability of M.leprae by mouse foot-pad and fluorescent staining techniques.
    Sreevatsa ; Katoch VM
    Indian J Lepr; 1994; 66(4):455-62. PubMed ID: 7714355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of brodimoprim on Mycobacterium leprae in vitro and in mouse foot-pads.
    Dhople AM; Ortega I; Seydel JK; Gardner GD
    Indian J Lepr; 1990; 62(1):76-86. PubMed ID: 2193064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of ascorbic acid in inhibiting the multiplication of M. leprae in the mouse foot pad.
    Hastings RC; Richard V; Christy SA; Morales MJ
    Int J Lepr Other Mycobact Dis; 1976; 44(4):427-30. PubMed ID: 798727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse foot pad technique for evaluation of drug resistance of M. leprae and other laboratory techniques to be used in leprosy control programmes.
    Pattyn SR
    Acta Leprol; 1983; 1(1):29-32. PubMed ID: 6401137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary dapsone resistance in leprosy.
    Vaishnavi C; Ganguly NK; Kumar B; Kaur S; Chakravarti RN
    Indian J Lepr; 1985; 57(3):507-13. PubMed ID: 3913705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo activity of K-130, a dihydrofolate reductase inhibitor, against Mycobacterium leprae.
    Dhople AM
    Arzneimittelforschung; 1999 Mar; 49(3):267-71. PubMed ID: 10219472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of severe combined immunodeficient mice to Mycobacterium leprae.
    Ishaque M; Sticht-Groh V; Togola D
    Microbios; 1996; 88(354):19-26. PubMed ID: 9121376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the involvement of the sciatic nerve following inoculation with M. leprae and other mycobacteria in the mouse foot pad.
    Kamala AN; Antia NH; Shetty VP
    Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):506-14. PubMed ID: 6100185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of desoxy fructo serotonin (DFS) on the multiplication of M. leprae in mouse foot-pad.
    Balakrishnan S; Mester L; Venkataramanaiah HN; Bhatia VN
    Lepr India; 1982 Jan; 54(1):56-8. PubMed ID: 7047899
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of radiometric macrophage assay and the mouse foot pad infection for the evaluation of Mycobacterium leprae sensitivity/resistance to dapsone.
    Sathish M; Rees RJ; Seshadri PS; Nath I
    Int J Lepr Other Mycobact Dis; 1985 Sep; 53(3):378-84. PubMed ID: 3900244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.